“Assessing Family Caregiver Needs: Policy and Practice Considerations,” by Lynn Feinberg, Ari Houser (July 2012, .pdf format, 4p.).
July 25, 2012
CAAR – Wisconsin Longitudinal Study Data Release – July 25, 2012
“WLS 12.28 data set is now available.” (July 24, 2012). For more information about this data release go to:
www.ssc.wisc.edu/wlsresearch/data/updates/change_notice/chnt_035.htm
Comments Off
CAAR – US Senate Special Committee on Aging Hearing Testimony – July 25, 2012
“Enhancing Women’s Retirement Security,” a hearing held July 25, 2012 (witness statements available in .pdf format, full hearing is available in Flash format, running time 1 hour 13 minutes).
Comments Off
CAAR – Statistics Canada/Statistique Canada Report – July 25, 2012
“Deaths, 2009,” (July 2012, .pdf and HTML format, 70p.).
Comments Off
CAAR – Medical Expenditure Panel Survey Data Release – July 25, 2012
The US Agency for Healthcare Research and Quality has released several new MEPS data files (July 2012, data in .zip or self decompressing [.exe] ASCII text and SAS Transport format, with documentation in HTML and .pdf format, and SAS and SPSS programming statements in ASCII format).
- HC-135G 2010 Office-Based Medical Provider Visits
meps.ahrq.gov/mepsweb/data_stats/download_data_files_detail.jsp?cboPufNumber=HC-135G
- HC-135F 2010 Outpatient Visits File
meps.ahrq.gov/mepsweb/data_stats/download_data_files_detail.jsp?cboPufNumber=HC-135F
- HC-135E 2010 Emergency Room Visits File
meps.ahrq.gov/mepsweb/data_stats/download_data_files_detail.jsp?cboPufNumber=HC-135E
Comments Off
CAAR – Center for Economic Studies/Ifo Institute for Economic Research (CESifo) [Munich, Bavaria, Germany] Working Paper – July 25, 2012
“The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010: Evidence from Longitudinal, Disease-Level Data,” by Frank Lichtenberg and Billie Pettersson (CESifo Working Paper No. 3894, July 2012, .pdf format, 20p.). Note: Links to the abstract and full-text can be found at:
Comments Off
CAAR – Agency for Healthcare Research and Quality Website – July 25, 2012
“Improving Patient Safety in Long-Term Care Facilities: Training Modules,” (July 2012, .pdf and HTML format). Note: This site provides three training modules: “Module 1: Detecting Change in a Resident’s Condition; Module 2: Communicating Change in a Resident’s Condition; and , Module 3: Falls Prevention and Management.”
Comments Off
CAAR – Ageing Well Network [Dublin, Ireland] Report – July 25, 2012
“The New Agenda on Ageing,” (July 2012, .pdf format, 294p.).
Comments Off
CAAR – Edward R. Roybal Institute on Aging [University of Southern California] Brief – July 25, 2012
“Current Conditions among Older Latinos and African Americans in Low- and Middle-Income Los Angeles Neighborhoods: Findings from Residents in Affordable Independent Living Senior Apartments,” by La Mikia Castillo, Donald A. Lloyd and Iris Aguilar (July 2012, .pdf format, 4p.).
Comments Off
CAAR – Heritage Foundation Discussion Paper – July 25, 2012
“Ethics and Health Care: Rethinking End-of-Life Care,” by Daniel Callahan and Peter Lawler (Center for Policy Innovation Discussion Paper #04, July 2012, .pdf format, 7p.). Links to an abstract and full text are available at:
www.heritage.org/research/reports/2012/07/ethics-and-health-care-rethinking-end-of-life-care
More information about HF:
Comments Off
CAAR – US House Committee on Ways and Means, Subcommittee on Health Hearing Testimony – July 25, 2012
“Physician Organization Efforts to Promote High Quality Care and Implications for Medicare Physician Payment Reform,” a hearing held on Jul. 24, 2012 (testmony available in .pdf format).
waysandmeans.house.gov/Calendar/EventSingle.aspx?EventID=303383
Comments Off
CAAR – Public Library of Science (PLoS) Articles – July 25, 2012
A. “Development of a Small D-Enantiomeric Alzheimer’s Amyloid-{beta} Binding Peptide Ligand for Future In Vivo Imaging Applications,” by Susanne Aileen Funke, Dirk Bartnik, Julian Marius Gluck, Kasia Piorkowska, Katja Wiesehan, Urs Weber, Balazs Gulyas, Christer Halldin, Andrea Pfeifer, Christian Spenger, Andreas Muhs, and Dieter Willbold (PLoS ONE 7(7): e41457. doi:10.1371/journal.pone.0041457, XML, HTML, and .pdf format, 10p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0041457
B. “Structure and Dynamics of Amyloid-{beta} Segmental Polymorphisms,” by Workalemahu M. Berhanu and Ulrich H. E. Hansmann (PLoS ONE 7(7): e41479. doi:10.1371/journal.pone.0041479, XML, HTML, and .pdf format, 12p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0041479
Comments Off
CAAR – National Bureau of Economic Research Working Paper – July 25, 2012
“Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009,” by Frank R. Lichtenberg (w18235, July 2012, .pdf format, 36p.).
Abstract:
We examine the impact of pharmaceutical innovation, as measured by the vintage of prescription drugs used, on longevity, using longitudinal, country-level data on 30 developing and high-income countries during the period 2000-2009. We control for fixed country and year effects, real per capita income, the unemployment rate, mean years of schooling, the urbanization rate, real per capita health expenditure (public and private), the DPT immunization rate, HIV prevalence and tuberculosis incidence.
Life expectancy at all ages and survival rates above age 25 increased faster in countries with larger increases in drug vintage. The increase in drug vintage was the only variable that was significantly related to all of these measures of longevity growth. Controlling for all of the other potential determinants of longevity did not reduce the vintage coefficient by more than 20%. Pharmaceutical innovation is estimated to have accounted for almost three-fourths of the 1.74-year increase in life expectancy at birth in the 30 countries in our sample between 2000 and 2009, and for about one third of the 9.1-year difference in life expectancy at birth in 2009 between the top 5 countries (ranked by drug vintage in 2009) and the bottom 5 countries (ranked by the same criterion).
Comments Off
